Weight and BMI are only one metric of physical and emotional health
HSA and FSA accounts are eligible for payment
Tirzepatide is started at a low dose that is gradually increased so it is important you use the medication exactly as directed

should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus Discontinue treatment in women at least 2 months before a planned pregnancy, owing to the long washout period for semaglutide Clinical Considerations Poorly controlled diabetes during pregnancy increases maternal risk for diabetic ketoacidosis, preeclampsia, spontaneous abortions, preterm delivery, stillbirth, and delivery complications Poorly controlled diabetes increases fetal risk for major birth defects, stillbirth, and macrosomia-related morbidity Lactation There are no data on the presence of semaglutide in human milk, the effects on the breastfed infant, or the effects on milk production In lactating rats, semaglutide was detected in milk at levels 3- to 12-fold lower than in maternal plasma Interactions Coadministration with insulin secretagogues (eg, sulfonylureas) or insulin may increase the risk of hypoglycemia

Prioritize Mental Health and Stress Management: Elevated stress levels may interfere with weight loss success